Pharma Supplier Inks $22M Deal With DOJ Over Inflated Prices
Pharmaceutical supplier Fagron Holding USA LLC has agreed to pay $22 million to put to rest two whistleblower suits alleging its subsidiaries inflated average wholesale prices for compound prescription ingredients, the...To view the full article, register now.
Already a subscriber? Click here to view full article